IMUX
IMUX
NASDAQ · Biotechnology

Immunic Inc

$6.99
-0.40 (-5.41%)
As of Nov 21, 10:53 PM ET ·
Day Range $6.97 — $7.56
52W Range $5.06 — $17.43
Open$7.35
Previous Close$7.39
Day High$7.56
Day Low$6.97
52W High$17.43
52W Low$5.06
Volume—
Avg Volume200.0K
Market Cap111.01M
P/E Ratio—
EPS$-4.20
SectorBiotechnology

Analyst Ratings

Strong Buy
19 analysts
18 Buy 1 Hold 0 Sell
Price Target +253.2% upside
Current
$6.99
Target
$24.69
$14.59 $24.69 avg $25.91

Key Financials

FY 2025 FY 2024 FY 2023
Revenue 12.96M 11.88M 13.51M
Net Income 575.0K 486.8K 473.9K
Profit Margin 4.4% 4.1% 3.5%
EBITDA 905.5K 814.6K 969.2K
Free Cash Flow 454.1K 555.8K 696.0K
Rev Growth -0.8% +15.7% +3.2%
Debt/Equity 0.71 1.01 0.86

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $286.20 +0.94% 48.5 501.19B
AMGN Amgen Inc $435.64 -0.72% 25.1 236.00B
GILD Gilead Sciences Inc $166.43 -0.06% — 208.61B
VRTX Vertex Pharmaceuticals Inc $515.02 -1.08% 32.6 129.77B
REGN Regeneron Pharmaceuticals $920.69 -0.29% 19.8 95.40B
ALNY Alnylam Pharmaceuticals Inc $143.82 -2.71% 7.3 19.80B

IMUX News

No news for IMUX yet

Quick Stats

Market Cap111.01M
P/E Ratio—
EPS$-4.20
Volume—
SectorBiotechnology